95 related articles for article (PubMed ID: 6722793)
1. Serum pseudouridine as a biochemical marker in the development of AKR mouse lymphoma.
Russo T; Colonna A; Salvatore F; Cimino F; Bridges S; Gurgo C
Cancer Res; 1984 Jun; 44(6):2567-70. PubMed ID: 6722793
[TBL] [Abstract][Full Text] [Related]
2. Pseudouridine: a modified nucleoside as biological marker in malignant lymphomas.
Rasmuson T; Björk GR
Cancer Detect Prev; 1983; 6(1-2):293-6. PubMed ID: 6883387
[TBL] [Abstract][Full Text] [Related]
3. Presence of prelymphoma cells in the bone marrow of the lymphomagenic virus-treated AKR mouse.
Takeuchi H; Kato A; Hays EF
Cancer Res; 1984 Mar; 44(3):1008-11. PubMed ID: 6198077
[TBL] [Abstract][Full Text] [Related]
4. Pseudouridine determination in blood serum as tumor marker.
Salvatore F; Russo T; Colonna A; Cimino L; Mazzacca G; Cimino F
Cancer Detect Prev; 1983; 6(6):531-6. PubMed ID: 6318996
[TBL] [Abstract][Full Text] [Related]
5. Pseudouridine: a prognostic marker in non-Hodgkin's lymphomas.
Rasmuson T; Björk GR
Cancer Detect Prev; 1985; 8(1-2):287-90. PubMed ID: 4064048
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell metabolism in AKR mice in the prelymphomatous phase.
Kahn SB; Cheung T; Lodise R; Brodsky I
Cancer Res; 1976 Jan; 36(1):194-9. PubMed ID: 1247999
[TBL] [Abstract][Full Text] [Related]
7. The use of receiver operating characteristic (ROC) curves analysis in the evaluation of the diagnostic efficiency of serum pseudouridine as a tumor marker.
Savoia M; Pane F; Fortunato G; Salvatore F; Sacchetti L
Ital J Biochem; 1988; 37(2):119-27. PubMed ID: 3403212
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
9. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
[TBL] [Abstract][Full Text] [Related]
10. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
12. Further characterization of the leukemogenic activity of haloperidol in mice.
Wunderlich V; Fey F; Sydow G
Neoplasma; 1987; 34(4):389-96. PubMed ID: 3658046
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Ly-1+ B-cell populations and IgH rearrangements in "normal" spleens and in lymphomas of AKR/J and AKR Fv-1b mice.
Rosner A; Peled A; Haran-Ghera N; Canaani E
Cancer Res; 1993 May; 53(9):2147-53. PubMed ID: 7683252
[TBL] [Abstract][Full Text] [Related]
14. Lymphomagenesis in AKR.Fv-1b congenic mice.
Haran-Ghera N; Peled A; Brightman BK; Fan H
Cancer Res; 1993 Jul; 53(14):3433-8. PubMed ID: 8324753
[TBL] [Abstract][Full Text] [Related]
15. Serum pseudouridine concentration as a marker of gastrointestinal cancer.
Higley B; De Mello J; Oakes DJ; Giles GR
Clin Oncol; 1982 Dec; 8(4):305-12. PubMed ID: 7168923
[No Abstract] [Full Text] [Related]
16. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of N2, N2-dimethylguanosine and pseudouridine as determined by radioimmunoassay for patients with malignancy.
Levine L; Waalkes TP; Stolbach L
J Natl Cancer Inst; 1975 Feb; 54(2):341-3. PubMed ID: 1117461
[TBL] [Abstract][Full Text] [Related]
18. Serial passage of tumors in mice in the study of tumor progression and testing of antineoplastic drugs.
Leibovici J
Cancer Res; 1984 May; 44(5):1981-4. PubMed ID: 6713396
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of the graft versus host reaction during allogeneic tumour enhancement.
Piazzon I; Déroche A; Pasqualini CD
Arch Geschwulstforsch; 1980; 50(4):322-6. PubMed ID: 7458579
[TBL] [Abstract][Full Text] [Related]
20. Urinary hypoxanthine and pseudouridine as indicators of tumor development in mesothelioma-transplanted nude mice.
Buhl L; Dragsholt C; Svendsen P; Hage E; Buhl MR
Cancer Res; 1985 Mar; 45(3):1159-62. PubMed ID: 3838262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
